Navigation Links
New Chromatography Detectors From Varian, Inc. Extend the Range of Universal Detection for HPLC and LC/MS
Date:3/3/2008

PALO ALTO, Calif., March 3 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) announced today the release of two new evaporative light scattering detectors (ELSD) for conventional and high speed liquid chromatography. With their universal response, full gradient and solvent compatibility, and excellent baseline stability, Varian ELSDs possess key advantages over conventional UV and RI detectors for busy pharmaceutical and analytical laboratories. In addition, they complement electrospray detection in LC/MS (Liquid Chromatography/Mass Spectrometry) for compounds that are difficult to ionize.

With the capability to deliver sub-ambient evaporation down to 10 degrees Celsius, the new Varian 385-LC provides maximum sensitivity for compounds with significant volatility below 30 degrees Celsius, giving it the widest application range of all ELSDs. The new Varian 380-LC is the instrument of choice for non-volatile compounds, including analyses where elevated temperature offers higher sensitivity.

Both instruments offer unrivalled flexibility and sensitivity, delivering a universal response down to the low nanogram range for trace analysis. Real time gas management eliminates solvent effects for constant response across a gradient. Digital data collection enables the detectors to be interfaced with multi-vendor analysis platforms and removes the need for analog to digital interfaces. The new instruments allow chromatographers to save time and improve productivity with on-the-fly adjustment of light source intensity for sample mixtures with a wide concentration range. Excellent reproducibility (plus or minus < 2%), greatly enhances productivity. Fast data output rates and extremely low dispersion are ideal for high speed LC, an increasingly important analytical technique.

"These programmable ELSDs provide chemists with unrivalled control of an analysis in real time," says Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "Varian's new 380-LC family of detectors bring sensitive and accurate detection capability to an even wider range of applications."

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,900 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2007 sales of $921 million, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

For more technical information about Varian's Scientific Instruments, please visit http://www.varianinc.com

For More Information, Contact:

Public Relations

Varian, Inc.

650.424.3845

pr@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
2. Varian, Inc. Reports First Quarter 2008 Results
3. Roche Extends Tender Offer for Ventana
4. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
5. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
6. Discussions With FDA on Pixantrone EXTEND (PIX301) Trial Provide Path for NDA Submission
7. MichBio Announces Expo Tours; Extends Deadline for Innovator Showcase Applications
8. ChemAxon and Agilent Technologies Sign Agreement Extending JChem Integration With Kalabie Electronic Lab Notebook
9. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
10. Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma
11. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... DIEGO , Dec. 8, 2016  Renova™ ... for congestive heart failure and type 2 diabetes, ... for a novel adeno-associated virus (AAV) vector developed ... , M.D., Ph.D., at Stanford University. The company ... its paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... and CARDIFF, UK (PRWEB) , ... December 08, ... ... very high precision light to control cells — optogenetics — is key to ... current state of the art, spatially patterned light projected via free-space optics stimulates ...
(Date:12/8/2016)... , December 8, 2016 ... Unternehmen für Molekulargenetik, erweitert seine Palette an anpassbaren ... NGS Custom FH Panels, das ein schnelles und ... ermöglicht. Das Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen ... (CNV) mit einem einzigen kleinen Panel und ermöglicht ...
(Date:12/8/2016)... BARCELONA, Spain , Dec. 8, 2016  Anaconda ... on the development of the next generation neuro-thrombectomy system ... the appointment of Tudor G. Jovin, MD to join ... to serve as a strategic network of scientific and ... progresses the development of the ANCD BRAIN ® ...
Breaking Biology Technology:
(Date:12/7/2016)... 2016 According to a new market research report "Emotion ... Expression, Voice Recognition), Service, Application Area, End User, And Region - Global Forecast ... USD 6.72 Billion in 2016 to USD 36.07 Billion by 2021, at a ... Reading ... MarketsandMarkets Logo ...
(Date:12/6/2016)... Dec. 6, 2016 Valencell , the leading ... has seen a third consecutive year of triple digit ... in 2016 with a 360 percent increase in companies ... increase was driven by sales of its wrist and ... in its technology for hearables for fitness and healthcare ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
Breaking Biology News(10 mins):